HLB Therapeutics Market Cap

HLB Therapeutics has a market cap or net worth of 241.8 billion as of February 6, 2026. Its market cap has decreased by -78.36% in one year.

Market Cap

241.80B

Enterprise Value

260.53B

Revenue

63.25B

Ranking

n/a

PE Ratio

n/a

Stock Price

2,880.00

Market Cap Chart

Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 241.80B, an increase of 128.53%. That is a compound annual growth rate of 5.34%.

Market Cap History

Date	Market Cap	% Change
Feb 6, 2026	241.80B	-4.00%
Dec 30, 2025	251.87B	-73.05%
Dec 30, 2024	934.49B	182.02%
Dec 28, 2023	331.36B	-9.25%
Dec 29, 2022	365.14B	-3.64%
Dec 30, 2021	378.91B	-51.22%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BINEX	454.78B
Anterogen.Co.,Ltd.	391.24B
JETEMA,	348.91B
Bioneer	325.98B
Helixmith	279.04B
EASY BIO,Inc.	248.78B
Genexine	201.02B
MedPacto	193.65B

Market Cap Rankings